Geisinger President and CEO David Feinberg plans to step down from the health system to take charge of the healthcare efforts at Google.
Using a deep learning algorithm and PET images of the brain, researchers trained an AI to spot Alzheimer’s over 6 years ahead of a clinical diagnosis.
Two years after its founding, Biomatics Capital Partners has raised $300 million for its second fund and signed on two new venture partners.
The FDA approved Ortho’s Vitros fourth-generation HIV combination test, which detects HIV-1 and HIV-2 antibodies and the p24 antigen.
Quest Diagnostics launched a direct-to-consumer service that allows users to order and pay for lab tests from home.
HeartHero, a startup developing a portable AED, will license VivaQuant’s ECG technology for the detection of potentially fatal heart arrhythmias.
BioCardia birngs on Mark Schwartz to be its vice president of clinical affairs as it moves forward with a phase 3 trial of its cell therapy.
A new trial published in Nature has seen a combination of spinal cord therapy (SCS) and physical therapy help patients walk again.
The Gordon and Betty Moore Foundation is setting its sights on improving diagnostics as it looks to sharpen accountability and reduce medical errors.
The FDA has slapped a Class I recall, its most serious and highest recall alert, for strips sold by Roche Diagnostics that are used to check warfarin levels.